SCHEMBL72172

SCHEMBL72172

Cc1ccc(C(=O)O[C@](C(=O)O)(C(=O)c2ccc(C)cc2)[C@@H](O)C(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 5/20 0.39
LMNA P02545 1/20 0.39
SRD5A2 P31213 1/20 0.39
CA2 P00918 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 2/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
MAPT P10636 3/20 0.36
CES2 O00748 2/20 0.35
CES1 P23141 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
AKR1C3 P42330 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72683 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL27955132 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL5461407 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL6532888 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL88252 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL2986285 1.00 TDP1 (0.42) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL7348978 0.99 TDP1 (0.41) TDP1ALDH1A1LMNASRD5A2CA2
SCHEMBL7355024 0.99 TDP1 (0.41) TDP1ALDH1A1LMNASRD5A2CA2
Water SCHEMBL3859938 0.99 TDP1 (0.41) TDP1ALDH1A1LMNASRD5A2CA2
Water SCHEMBL1322825 0.99 TDP1 (0.41) TDP1ALDH1A1LMNASRD5A2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3946 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276974-A1 PROCESS FOR PREPARING ZANUBRUTINIB IN AMORPHOUS FORM OLON S.P.A. (IT) 2025-09-04 US claimed
WO-2025133917-A1 PROCESS FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5- ETHOXY-1, 4-DIHYDRO-2,8-DIMETHYL-1,6-NAPTHYRIDINE-3-CARBOXAMIDE INDUSTRIALE CHIMICA S.R.L. (IT) 2025-06-26 WO claimed
US-20250115601-A1 PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF ALIVUS LIFE SCIENCES LIMITED (IN) 2025-04-10 US claimed
EP-4526302-A1 PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF Alivus Life Sciences Limited (IN) 2025-03-26 EP claimed
EP-4401725-A1 PREPARATION OF OPTICALLY ACTIVE ENANTIOMERS OF PIPERONYL AMINES BY RESOLUTION OF THE DIASTEREOMERIC SALTS atai Life Sciences AG (DE) 2024-07-24 EP claimed
WO-2024147053-A1 IMPROVED PROCESS FOR THE PREPARATION OF FINERENONE OPTIMUS DRUGS PVT LTD (IN) 2024-07-11 WO claimed
WO-2024075139-A1 A PROCESS FOR PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF MAITHRI DRUGS PRIVATE LIMITED (IN) 2024-04-11 WO claimed
CN-113121413-B Preparation method of key intermediate of JAK3 enzyme inhibitor 江苏艾立康医药科技有限公司 2024-04-09 CN claimed
WO-2023226900-A1 2-(PIPERAZINE-2-YL) ACETONITRILE DERIVATIVE, PREPARATION METHOD FOR, AND USE THEREOF 苏州泽璟生物制药股份有限公司 2023-11-30 WO claimed
WO-2023223188-A1 PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF GLENMARK LIFE SCIENCES LIMITED (IN) 2023-11-23 WO claimed
EP-1017695-A1 RESOLUTION OF OPTICALLY-ACTIVE COMPOUNDS MONASH UNIVERSITY (AU) 2000-07-12 EP claimed
EP-0787115-B1 PROCESS FOR PRODUCING DERIVATIVES OF 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINE SANOCHEMIA PHARMAZEUTIKA AG (AT) 2000-01-05 EP claimed
EP-0968212-A1 METHOD OF MAKING (1S, 4R)-1-AZABICYCLO 2.2.1]HEPTAN-3-ONE AND (1R, 4S), 1-AZABICYCLO 2.2.1]HEPTAN-3-ONE WARNER-LAMBERT COMPANY (US) 2000-01-05 EP claimed
WO-1999016769-A1 RESOLUTION OF OPTICALLY-ACTIVE COMPOUNDS MONASH UNIVERSITY (AU) 1999-04-08 WO claimed
WO-1999002513-A1 PREPARATION OF DIARYL-BENZOPYRANS NOVO NORDISK A/S (DK) 1999-01-21 WO claimed
WO-1998032759-A1 METHOD OF MAKING (1S, 4R)-1-AZABICYCLO[2.2.1]HEPTAN-3-ONE AND (1R, 4S), 1-AZABICYCLO[2.2.1]HEPTAN-3-ONE WARNER LAMBERT COMPANY (US) 1998-07-30 WO claimed
WO-1996033163-A1 CHIRAL HYDRAZINE DERIVATIVES SCHERING CORPORATION (US) 1996-10-24 WO claimed
EP-0456196-A1 Pyrrolo,[2,3-b]indole-ketones and analogs, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-11-13 EP claimed
EP-0251904-B1 PROCESS FOR THE PREPARATION OF ACIDIC LEVOMEPROMAZINE MALEATE RHONE-POULENC SANTE (FR) 1990-01-10 EP claimed
US-4798895-A Process for preparing levomepromazine hydrogen maleate RHONE-POULENC SANTE (FR) 1989-01-17 US claimed